Our Portfolio
Cryptopharma is a Company focused on the discovery and development of novel anti-inflammatory therapeutic agents for treatment of pulmonary diseases. The Company’s initial focus is on the development of CP92, a treatment of Cystic Fibrosis. Second generation compounds are in development with the potential to treat other inflammatory conditions including asthma and chronic obstructive pulmonary disease (COPD). See www.cryptopharma.com
Warm Contact designs and manufactures products which increase the comfort of patients using eye care treatments. The Company's first product is a lens warmer that offers increased patient comfort and is particularly useful to new users of contact lens who experience the anxiety surrounding the initial shock of inserting cool lenses into their eyes. See www.warmcontact.com
Dosimetry & Imaging is a Company focused on the development of a novel X-ray storage phosphor for use in radiation detection (dosimetry) and medical imaging. See www.(website under construction)
Synergetic Services Pty Ltd is a software development company aiming to revolutionise the process by which applicants source personal loans when shopping online for major purchases such as motor vehicles. The company has created a personal loan procurement system which empowers consumers; enables choice of loan product and financial institution; performs real-time identity and credit validation and approval of loan applications. When linked with online-market sales, a person can choose a new or used motor vehicle and apply for finance at the same time and receive immediate loan confirmation. Alternatively, a pre-approved spending level can also be obtained in the same manner. See www.(website under construction).
The focus of Savine Therapeutics is to develop and commercialise vaccines for prevention and treatment of diseases with a significant unmet medical need using it's proprietary Scrambled Antigen Vaccine (SAVINE) technology. The technology was invented by researchers in the John Curtin School of Medical Research at the Australian National University. It enables production of vaccines suitable for a broad range of serious worldwide infectious diseases and cancers. See www.savine.com